ASX Large Caps: Shares up 1pc as coal stocks Whitehaven, Yancoal jump on quarterly updates
ASX ends the week on a high note, up 1pc Market bullish after strong outlook by global giant, TSMC Coal mining stocks Yancoal and Whitehaven [more…]
Ethical Investor: Energy transition to be as big as industrial or digital revolution, and these 3 ASX stocks could benefit
The energy transition could be as big as the industrial or digital revolution But the market may not be pricing in the speed of the [more…]
ASX Small Cap Lunch Wrap: Who made a solid play for the title of ‘Dumbest Canadian Ever’ this week?
The local market has found some spunk on Friday morning, leaving the benchmark indices looking happier mid-morning than they have been in quite some time. [more…]
Resources Top 5: Life is a (nickel) Highway for Mantle, Cyclone blows in with 50pc gain
Who said nickel was in the dumps right now? Oh, wait, we did… still, Mantle is up on an upgraded nickel resource estimate Iggy Tan-backed [more…]
What’s in store for 2024: Brightstar Resources
Stockhead’s Sarah Hughan sits down with Brightstar Resources (ASX:BTR) managing director Alex Rovira to close the books on 2023 and gain a sneak peek into [more…]
Ground Breakers: Whitehaven shops potential met coal stake, sees support for thermal prices
Whitehaven Coal says thermal coal prices are being supported after a more than 60% fall last year Coal giant is looking at potential sell-down of [more…]
Viridis remains on track to produce a Colossus maiden rare earths resource
Phase I and II drilling at Colossus nears completion Viridis says results will underpin an upcoming maiden resource estimate Aggressive RC and diamond drilling to [more…]
Adavale Resources keeping up the nickel exploration pace at Kabanga Jirani
Adavale Resources plans to carry out a deep penetrating ground EM survey and potential follow-up drill testing at HEM 4 A sixth diamond hole at [more…]
ASX Health Stocks: Mesoblast rockets 20pc after being granted Rare Pediatric Disease Designation by FDA
Mesoblast granted Rare Pediatric Disease (RPD) Designation by FDA Visioneering Technologies releases its full 1-year results on children with myopia Mesoblast blasts away 20pc [more…]
The Secret Broker: Then I saw her shorts… now I want to leave her!
After 35 years of stockbroking for some of the biggest houses and investors in Australia and the UK, the Secret Broker is regaling Stockhead readers [more…]